AngioDynamics, Inc. (AngioDynamics), a public medical device company, is engaged in designing, developing, manufacturing and marketing therapeutic and diagnostic devices for the treatment of peripheral vascular disease (PVD) and other non-coronary diseases. It focuses on the development of innovative, minimally invasive, image-guided procedures to treat PVD and oncology therapy options including radiofrequency ablation, systems, irreversible electroporation, surgical resection systems and embolization products for the treatment of cancer. The company offers its products to interventional physicians, interventional radiologists, vascular surgeons and others. It holds three wholly owned subsidiaries and its products are sold through direct sales force in the US and through a network of distributors outside the US markets. The company operates principally in the US and Europe. It is headquartered in New York, the US.

Street: 
603 Queensbury Avenue
City: 
Queensbury
Postcode: 
12804
Federal State : 
United States
WebSite: 
www.angiodynamics.com
Fax: 
1-518-7981360

Company Index Score

Current Index Score Historical Index Score
  • AngioDynamics, Inc. currently scores 50 % in the index.
  • AngioDynamics, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • AngioDynamics, Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets